Nutex Health Inc. · NASDAQ:NUTX
Nutex Health — Investor Presentation (September 2025)
17 slides from Nutex Health's investor presentation, September 2025
Slide 1: S TR I CTL Y P RI V A TE A N D CON
S TR I CTL Y P RI V A TE A N D CON FI DE N TI A L STR I CTL Y PRI VATE AN D CON FI DEN TI AL
Slide 2: Disclaimer
Disclaimer General The information contained in this Investor Presentation (“Presentation”) has been prepared by Nutex Health Inc. (“NUTX” or the “Company”) for investors, solely for informational purposes. The Presentation has been prepared to assist prospective investors in making their own evalua
Slide 3: Forward looking statements
Forward looking statements Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases “will”, "will likely result," "expected to,"
Slide 4: Agenda
Agenda 1 Business Overview 2 Appendix CO NF I DE NT I AL 4
Slide 5: Management Team With Deep Experience in Healthcare
Management Team With Deep Experience in Healthcare Thomas T. Vo, M.D., MBA Warren Hosseinion, M.D. Jon Bates, MBA, CPA Wesley Bamburg, FACHE Chief Executive Officer President Chief Financial Officer Chief Operating Officer Master of Business Administration ER Physician CEO Co-Founder & CEO VP of Acc
Slide 6: Our mission, vision, and values
Our mission, vision, and values Our Mission To make exceptional concierge-level health care more accessible to all communities, with a practice centered on patient experience and satisfaction Our Vision To be leaders and innovators in the small hospital space Our Values Patient care is our number on
Slide 7: Nutex at-a-glance
Nutex at-a-glance ◼ Owns and operates a comprehensive and integrated care delivery platform comprised of: Company Highlights ◼ Hospital Division – Develops and operates a network of micro-hospitals, specialty hospitals, and hospital outpatient departments – A micro-hospital is a small hospital inclu
Slide 8: Overview of Nutex's hospital division
Overview of Nutex’s hospital division Nutex’s Innovative Micro-Hospitals Meet their served Communities Demand for Higher Acuity Care Address Challenges of Traditional Care Access Points Network of strategically located, state-of-the-art micro-hospitals across the U.S. which service ER visits at eq
Slide 9: Nutex's micro-hospitals treat ER acuities at a fraction of the wait time
Nutex’s micro-hospitals treat ER acuities at a fraction of the wait time Nutex’s facilities require lower staffing and capital obligations while delivering improved quality of care, with an average patient wait time under 30 minutes The majority of cases treated at a Nutex micro-hospital are acuity
Slide 10: Turn-key de novo strategy delivering compelling and scalable facility economics
Turn-key de novo strategy delivering compelling and scalable facility economics De Novo Facility Profile De Novo Rollout Timeline ◼ Provide emergency, inpatient care, outpatient imaging, outpatient Task Timing labs, minor procedures, etc. Services / Staffing ◼ ER Physician, RNs, Radiology Technologi
Slide 11: Overview of Nutex's population health management division
Overview of Nutex’s population health management division ◼ Nutex operates 4 IPAs: Company Highlights ◼ Clinical quality reporting (STAR, HEDIS, MIPS, ACO reports) ◼ Nutex IPAs (Independent Practice Associations) ◼ AHP IPA (Los Angeles): 30,000+ patients, 140+ primary care physicians, 400+ specialis
Slide 12: Our vision is to create a coordinated, integrated, risk-bearing care delivery model
Our vision is to create a coordinated, integrated, risk-bearing care delivery model ◼ Pioneering platform which combines a national network of patient-centric micro-hospitals with wraparound primary care capabilities Network of micro- Risk-bearing hospitals provider ◼ Proven track record in networks
Slide 13: Selected External Growth Opportunities
Selected External Growth Opportunities Core Nutex Opportunities Emerging Nutex and Micro-Hospital Opportunities IPA Development Joint Ventures ▪ Acquire or start IPAs ▪ Develop and operate facilities on behalf of health ▪ Increase capitation and full-risk contracting systems Facility Development Dig
Slide 14: Financial Overview
Financial Overview Historical Financials - Annual Commentary • Total revenue of $479.9 million as compared to total revenue of $247.6 million for the year ended December 31, 2024, an increase of 93.8%. Of this revenue growth, revenue from mature hospitals, which are hospitals opened prior to ($ in m
Slide 15: Financial Overview
Financial Overview Historical Financials - Quarterly Commentary • Total revenue increased $144.3 million to $211.8 million for the three months ended March 31, 2025 as compared to total revenue of $67.5 million for the same period in 2024, an increase of 213.8%. Revenue from mature hospitals, which
Slide 16: Board of Directors With Deep Experience in Healthcare
Board of Directors With Deep Experience in Healthcare Thomas T. Vo, M.D., MBA Chief Executive Officer Scott J. Saunders Kelvin Spears, M.D. Director Director o Mr. Saunders is head of health care advisory services and has been Managing o Dr. Spears is Board Certified in Emergency Medicine and has ov
Slide 17: Investment Highlights
Investment Highlights Well-positioned for major trends in a large and attractive market (high-quality, medium-acuity patient- 1 centric hospital with inpatient care and value-based outpatient care) Deep value proposition to the healthcare ecosystem from our comprehensive portfolio of coordinated 2 a
Nutex Health — Investor Presentation (September 2025) on 6ix